Author:
Khire Achyut,Vavia Pradeep
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Walters KA. Dermatological and transdermal formulations. New York: Marcel Dekker Inc; 2002.
2. Shaefer U, Hansen S, Schneider M, Contreras JL, Lehr CM. Models for skin absorption and skin toxicity testing. In: Errhardt C, Kim KJ, editors. Drug absorption studies: in situ, in vitro and in silico models. London: Springer; 2008. p. 4–20.
3. Surber C, Davis A. Bioavailability and bioequivalence of dermatological formulations. In: Walters KA, editor. Dermatological and transdermal formulations. New York: Marcel Dekker; 2002.
4. Skelly JP, Shah VP, Maibach HI, Guy RH, Wester RC, Flynn GL, et al. FDA and AAPS report of the workshop on principles and practices of in vitro percutaneous penetration studies: relevance to bioavailability and bioequivalence. Pharm Res. 1987;4:265–7.
5. Shah VP, Elkins J, Skelly JP. Relationship between in vivo skin blanching and in vitro release rate for betamethasone valerate creams. J Pharm Sci. 1992;81:104–6.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献